巴曲酶和银杏叶提取物注射液治疗高龄患者突发性耳聋的疗效

发布时间：2019-01-29 00:00

【摘要】：目的比较巴曲酶和银杏叶提取物注射液用于治疗突发性耳聋的临床疗效。方法 2010年1月~2012年6月在本院耳鼻喉科就诊的突发性耳聋患者124例随机为巴曲酶组和银杏叶提取物组,每组各62例。两组患者除了均接受基础治疗外分别接受巴曲酶注射液和银杏叶提取物注射液治疗。比较两组患者的临床疗效、受损频率听力阈值及并发症状的恢复时间。结果①银杏叶提取物组患者的总有效率为88.71%,显著高于巴曲酶组(P0.01);②银杏叶提取物组患者呕吐、耳鸣和眩晕伴随症状恢复正常时间分别为(3.43±0.72)d、(5.39±1.23)d和(8.17±1.37)d,均较巴曲酶组患者显著缩短(P0.05或P0.01);③银杏叶提取物组患者治疗后受损频率听力阈值为(55.39±12.37)dB,较巴曲酶组显著降低(P0.01)。结论银杏叶提取物注射液治疗突发性耳聋临床疗效显著优于巴曲酶注射液,值得临床推荐。
[Abstract]:Objective to compare the clinical effects of batroxobin and ginkgo biloba extract injection in the treatment of sudden deafness. Methods from January 2010 to June 2012 124 patients with sudden deafness were randomly divided into batroxobin group and ginkgo biloba extract group with 62 cases in each group. In addition to basic treatment, the two groups were treated with batroxobin injection and ginkgo biloba extract injection respectively. The clinical efficacy, hearing threshold and recovery time of complications were compared between the two groups. Results 1the total effective rate of Ginkgo biloba extract group was 88.71, which was significantly higher than that of batroxobin group (P0.01). 2 the recovery time of symptoms associated with vomiting, tinnitus and vertigo in Ginkgo biloba extract group was (3.43 卤0.72) d, (5.39 卤1.23) d and (8.17 卤1.37) d, respectively. Compared with batroxobin group, it was significantly shorter (P0.05 or P0.01). 3After treatment, the hearing threshold of Ginkgo biloba extract group was (55.39 卤12.37) dB, significantly lower than that of batroxobin group (P0.01). Conclusion Ginkgo biloba extract injection is superior to Batroxobin injection in the treatment of sudden deafness.
【作者单位】：齐齐哈尔医学院第二附属医院;
【分类号】：R764.43

【参考文献】